Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, announces today the launch of two new proprietary cultivars in Poland, marking the highest ...

Aurora Cannabis Inc. closed 37.64% short of its 52-week high of $7.20, which the company achieved on August 15th.

Aurora Cannabis Inc. closed 36.39% below its 52-week high of $7.20, which the company reached on August 15th.

Download the Complete Report Here By Rayk Riechmann Aurora Cannabis (Nasdaq: ACB) continued to fly high as it closed out fiscal 2025, with net revenue topping street estimates and prospects ...

Aurora's CEO defends partnership with PMI-owned Aspeya, saying it's about science, not Big Tobacco. Here's what we learned.

Aurora Cannabis Inc. (NASDAQ:ACB) Q4 2025 Earnings Call Transcript June 18, 2025 Aurora Cannabis Inc. misses on earnings expectations. Reported EPS is $0.07 EPS, expectations were $0.11.

Canadian LPs offer better balance sheets and global potential vs. U.S. MSOs in cannabis investing. Find out why fundamentals ...

NEW YORK, June 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Aurora Cannabis Inc. (“Aurora Cannabis” or the “Company”) (NASDAQ: ACB). Such ...

NEW YORK, June 27, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Aurora Cannabis Inc. ("Aurora Cannabis" or the "Company") (NASDAQ: ACB). Such investors are ...

Aurora Cannabis issued a press release on June 18, 2025, reporting its financial results for the Company's fiscal fourth quarter and full year.